SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,420,622 | +11.9% | 77,401 | +1.5% | 0.07% | +17.7% |
| Q2 2023 | $14,677,577 | -34.1% | 76,263 | -30.6% | 0.06% | -38.6% |
| Q1 2023 | $22,262,184 | +62.0% | 109,953 | +2.7% | 0.10% | +50.7% |
| Q4 2022 | $13,743,176 | -8.2% | 107,057 | -2.1% | 0.07% | -11.8% |
| Q3 2022 | $14,968,000 | -19.5% | 109,397 | +4.0% | 0.08% | -12.6% |
| Q2 2022 | $18,603,000 | -6.4% | 105,140 | -23.8% | 0.09% | +11.5% |
| Q1 2022 | $19,882,000 | -8.1% | 138,027 | +1.3% | 0.08% | +4.0% |
| Q4 2021 | $21,634,000 | -4.8% | 136,190 | +1.8% | 0.08% | -13.8% |
| Q3 2021 | $22,718,000 | +8.8% | 133,796 | +1.2% | 0.09% | +11.5% |
| Q2 2021 | $20,871,000 | +13.7% | 132,201 | +0.0% | 0.08% | +6.8% |
| Q1 2021 | $18,349,000 | -21.3% | 132,143 | +5.4% | 0.07% | -24.0% |
| Q4 2020 | $23,323,000 | – | 125,370 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |